Goodwill and Intangible Assets

9 Months Ended

Mar. 31, 2015

(10)	Goodwill and Intangible Assets

Goodwill

The following summary sets forth the changes in goodwill for the nine months ended March 31, 2015:


(In thousands)	Gross Carrying Amount
Beginning balance at June 30, 2014	$	169,181
Acquisition of the clinic		16,576
Translation adjustments		(529	)

Ending balance at March 31, 2015		185,228

At March 31, 2015, the Company had recorded goodwill of $185.2 million, net of translation adjustments, related to the acquisitions of Myriad RBM, Inc. on May 31, 2011 (formerly Rules-Based Medicine, Inc.), Crescendo on February 28, 2014 and the Clinic on February 27, 2015.

Intangible Assets

Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and trade names as well as non-amortizable intangible assets of in-process technologies and research and development. The following summarizes the amounts reported as intangible assets:


(In thousands)	Gross Carrying		Accumulated
March 31, 2015:	Amount		Amortization			Net
Purchased licenses and technologies	$	199,100	$	(13,719	)	$	185,381
Customer relationships		4,650		(1,790	)		2,860
Trademarks		3,000		(350	)		2,650

Total amortizable intangible assets		206,750		(15,859	)		190,891

In-process research and development		4,800		—			4,800

Total non-amortizable intangible assets		4,800		—			4,800

Total intangible assets	$	211,550	$	(15,859	)	$	195,691


(In thousands)	Gross Carrying		Accumulated
June 30, 2014:	Amount		Amortization			Net
Purchased licenses and technologies	$	201,100	$	(6,597	)	$	194,503
Customer relationships		4,650		(1,441	)		3,209
Trademarks		3,000		(200	)		2,800

Total amortizable intangible assets		208,750		(8,238	)		200,512

In-process research and development		4,800		—			4,800

Total non-amortizable intangible assets		4,800		—			4,800

Total intangible assets	$	213,550	$	(8,238	)	$	205,312

The Company recorded amortization expense during the respective periods for these intangible assets as follows:


(In thousands)	Three months ended March 31,				Nine months ended March 31,
	2015		2014		2015		2014
Amortization of intangible assets	$	3,136	$	1,146	$	9,621	$	1,634

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References+ Details